Persons exposed to once-weekly semaglutide were more likely to be married or living with a partner, had a longer duration of diabetes, higher values of hemoglobin A1c and estimated glomerular filtration rate, and were more likely to use insulin and non-insulin glucose-lowering medicine, and to have diabetic retinopathy. This evidence concerns the gene INS and diabetic retinopathy.